4.7 Article

One-year follow-up of medication management capacity in highly functioning older adults

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/gerona/55.10.M550

关键词

-

资金

  1. NIA NIH HHS [AG00251, AG608812, AG00294] Funding Source: Medline

向作者/读者索取更多资源

Background, We tested the hypothesis that impairment in the ability to take medication independently predicts early functional decline. Methods. A 12-month, prospective cohort study was performed at two continuing-care retirement facilities using the Drug Regimen Unassisted Grading Scale (DRUGS). This geriatric screening tool utilizes a stepwise progression of four tasks: (i) identification, (ii) access, (iii) dosage, and (iv) timing. Results, Forty-seven (86%) of the eligible participants completed the 12-month follow-up assessment; three were transferred to skilled nursing facilities. The mean age at study entry was 84.2 i: 5.1 years; 72% of the participants were women, and 68% were college educated. At 12 months there was a decline in the Mini-Mental State Examination (MMSE) score(p = .029), an increase in the timed Up and Go test(p = .023), and a decline in the DRUGS score (p = .029). Nine (18%) of the participants resided in assisted- versus independent-living situations compared with three par participants (5%) at study entry (p = .031). Both 12-month DRUGS score and 12-month self-reported medication manage ment capacity were associated with 12-month MMSE (p = .0001 and p = .019, respectively). Baseline DRUGS score was associated with 12-month MMSE and Geriatric Depression Scale scores (p = .0002 and p = .002, respectively). Both baseline DRUGS score and self-reported medication management capacity were also associated with residence in assisted-living communities at 6 months (p = .029 and p = .040, respectively). MMSE was not associated with any of the clinical outcomes. Conclusions. The DRUGS tool may predict functional decline in highly functioning older adults.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据